Articles related to BLOOD DISORDERS
The Devil is in the Details: Approach to Refractory Hypokalemia
Follow this case study of a 71-year-old man found to have significant, asymptomatic hypokalemia discovered in routine outpatient lab work. How would you manage this patient?
Cardiology April 19th 2022
Complement and the Prothrombotic State
Parallels and distinct features among paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) are discussed against the background of thrombosis, complement activation via eculizumab, and potential complement diagnostic and therapeutic avenues.
Hematology April 5th 2022
Analysis of Platelet Count and New Cancer Diagnosis Over a 10-Year Period
Individuals with cancer often have an elevated platelet count at the time of diagnosis. But what, if any, is the relationship? This study of nearly nine million individuals followed over 10 years points to a positive correlation.
Hematology January 25th 2022
The Longitudinal Dynamics and Natural History of Clonal Hematopoiesis (CH)
In this late-breaking abstract from the ASH Annual Meeting & Exhibition, the researches wanted to address the limited understanding of how and when CH develops, what factors govern its behavior, how it interacts with aging, and how these variables relate to malignant progression. Here are the results from analyzing 1,593 blood DNA samples from 385 elderly individuals, each sampled up to 5 times over approximately 13 years.
Hematology December 7th 2021
Algorithmic Approach to Identify Patients With Germline Predisposition Syndromes (GPS), Including Those With Hematologic Malignancies
Review Publication: Hematology AdvisorDesign: At the Annual Meeting of the Society of Hematologic Oncology, researchers presented a study identifying a higher percentage of patients with germline predisposition syndromes (GPS).Results: Following a review of medical records of patients diagnosed with GPS between 1994 and 2018, the investigators reported that the detection of GPS positively impacted medical care in 91% of cases, including proper selection of a bone marrow donor, selection of drug and conditioning regimens, and genetic counseling.
Hematology September 21st 2021
Marrow or Peripheral Blood for Allogeneic Transplant: Are We Ignoring the Data?
Despite peripheral blood making up 80% of all of hematopoietic cell transplants, there are similar rates of overall survival, disease-free survival, and transplant-related mortality when comparing marrow and peripheral blood as graft sources. Chronic graft-versus-host disease (GVHD) and cytokine release syndrome (CRS) are more significant in those who received peripheral blood, yet the standard of care hasn’t changed. Here, two doctors reflect on the debate.
Hematology September 7th 2021